BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu C, Li L. The immunoregulation of mesenchymal stem cells plays a critical role in improving the prognosis of liver transplantation. J Transl Med. 2019;17:412. [PMID: 31823784 DOI: 10.1186/s12967-019-02167-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zheng T, Shao W, Tian J. Exosomes derived from ADSCs containing miR-378 promotes wound healing by targeting caspase-3. J Biochem Mol Toxicol 2021;:e22881. [PMID: 34392575 DOI: 10.1002/jbt.22881] [Reference Citation Analysis]
2 Pang Q, Qian N, Zou W, Yang Y, Chen H, Zhang M, Zhang Q, Ao J, Zhang T. PBMSCs transplantation facilitates functional recovery after spinal cord injury by regulating microglia/macrophages plasticity. Transplant Immunology 2022;72:101592. [DOI: 10.1016/j.trim.2022.101592] [Reference Citation Analysis]
3 He YT, Zhu XL, Li SF, Zhang BQ, Li Y, Wu Q, Zhang YL, Zhou YY, Li L, Qi YN, Bao J, Bu H. Creating rat hepatocyte organoid as an in vitro model for drug testing. World J Stem Cells 2020; 12(10): 1184-1195 [PMID: 33178400 DOI: 10.4252/wjsc.v12.i10.1184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Pang Q, Chen S, Fu S, Zhou H, Zhang Q, Ao J, Luo X, Zhang T. Regulatory Role of Mesenchymal Stem Cells on Secondary Inflammation in Spinal Cord Injury. JIR 2022;Volume 15:573-93. [DOI: 10.2147/jir.s349572] [Reference Citation Analysis]
5 Zhu D, Wu ZH, Xu L, Yang DL. Single sample scoring of hepatocellular carcinoma: A study based on data mining. Int J Immunopathol Pharmacol 2021;35:20587384211018389. [PMID: 34053310 DOI: 10.1177/20587384211018389] [Reference Citation Analysis]
6 Wu MC, Meng QH. Current understanding of mesenchymal stem cells in liver diseases. World J Stem Cells 2021; 13(9): 1349-1359 [PMID: 34630867 DOI: 10.4252/wjsc.v13.i9.1349] [Reference Citation Analysis]
7 Sharma M, Kulkarni A, Sasikala M, Kumar P, Jaggaiahgari S, Pondugala K, Jaishetwar G, Darisetty S, Jagtap N, Gupta R, Singh JR, Fatima S, Rao PN, Rao GV, Reddy DN. Long-term Outcome of Autologous Hematopoietic Stem Cell Infusion in Cirrhosis: Waning Effect over Time. J Clin Transl Hepatol 2020;8:385-90. [PMID: 33447521 DOI: 10.14218/JCTH.2020.00052] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ronca V, Wootton G, Milani C, Cain O. The Immunological Basis of Liver Allograft Rejection. Front Immunol 2020;11:2155. [PMID: 32983177 DOI: 10.3389/fimmu.2020.02155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
9 Zhu Y, Geng S, Li Q, Jiang H. Transplantation of Mesenchymal Stem Cells: A Potential Adjuvant Therapy for COVID-19. Front Bioeng Biotechnol 2020;8:557652. [PMID: 33224928 DOI: 10.3389/fbioe.2020.557652] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
10 Govindasamy V, Rajendran A, Lee ZX, Ooi GC, Then KY, Then KL, Gayathri M, Kumar Das A, Cheong SK. The potential role of mesenchymal stem cells in modulating antiageing process. Cell Biol Int 2021. [PMID: 34245637 DOI: 10.1002/cbin.11652] [Reference Citation Analysis]
11 Masalova OV, Lesnova EI, Klimova RR, Ivanov AV, Kushch AA. Mesenchymal Stem Cells Can Both Enhance and Inhibit the Cellular Response to DNA Immunization by Genes of Nonstructural Proteins of the Hepatitis C Virus. Int J Mol Sci 2021;22:8121. [PMID: 34360889 DOI: 10.3390/ijms22158121] [Reference Citation Analysis]
12 Goldsteen PA, Yoseif C, Dolga AM, Gosens R. Human pluripotent stem cells for the modelling and treatment of respiratory diseases. Eur Respir Rev 2021;30:210042. [PMID: 34348980 DOI: 10.1183/16000617.0042-2021] [Reference Citation Analysis]
13 Xu SJ, Ye LP, Wang W, Chen YH, Dong J, Mao XL, Li SW. Role of the Microenvironment in Mesenchymal Stem Cell-Based Strategies for Treating Human Liver Diseases. Stem Cells Int 2021;2021:5513309. [PMID: 34824587 DOI: 10.1155/2021/5513309] [Reference Citation Analysis]
14 Yang Y, Chen Y, Zhao Y, Ji F, Zhang L, Tang S, Zhang S, Hu Q, Li Z, Zhang F, Li Q, Li L. Human menstrual blood-derived stem cell transplantation suppresses liver injury in DDC-induced chronic cholestasis. Stem Cell Res Ther 2022;13. [DOI: 10.1186/s13287-022-02734-1] [Reference Citation Analysis]
15 Hu C, Zhao L, Li L. Genetic modification by overexpression of target gene in mesenchymal stromal cell for treating liver diseases. J Mol Med (Berl) 2021;99:179-92. [PMID: 33388882 DOI: 10.1007/s00109-020-02031-5] [Reference Citation Analysis]
16 Yang Y, Zhao Y, Zhang L, Zhang F, Li L. The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues. Front Med (Lausanne) 2021;8:655268. [PMID: 34136500 DOI: 10.3389/fmed.2021.655268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhang L, Ma XJ, Fei YY, Han HT, Xu J, Cheng L, Li X. Stem cell therapy in liver regeneration: Focus on mesenchymal stem cells and induced pluripotent stem cells. Pharmacol Ther 2021;:108004. [PMID: 34597754 DOI: 10.1016/j.pharmthera.2021.108004] [Reference Citation Analysis]
18 Kebria MM, Milan PB, Peyravian N, Kiani J, Khatibi S, Mozafari M. Stem cell therapy for COVID-19 pneumonia. Mol Biomed 2022;3:6. [PMID: 35174448 DOI: 10.1186/s43556-021-00067-8] [Reference Citation Analysis]
19 Liu L, Yang F. Application of Modified Mesenchymal Stem Cells Transplantation in the Treatment of Liver Injury. Physiol Res. [DOI: 10.33549/physiolres.934623] [Reference Citation Analysis]